# Dalteparin

## Fragmin 10000 IU(Anti-Xa)/4mL

| 藥物代碼           | IFRA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Treatment of acute deep venous thrombosis. Prevention of clotting in the extracorporeal system during hemodialysis & hemofiltration.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 副作用             | Reversible non-immunologically-mediated thrombocytopenia (type 1), transient elevation of liver transaminases, bleeding, hematoma at inj site, allergic reactions, pain at inj site.Dermatologic: Hematoma, Injection site (7% to 35%), Injection site pain (4.5% to 12% )Hematologic: HematomaOther: Irritation symptom, Local                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 禁忌               | Confirmed or suspected history of immunologically-mediated heparin-induced thrombocytopenia. Active, clinically significant bleeding (eg. GI ulceration or bleeding or cerebral hemorrhage). Severe coagulation disorders, septic endocarditis. Recent injury to, or surgical procedures of, the CNS, eyes &/or ears.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 藥物保存方式       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 用法用量           | General surgery with associated risk of thromboembolic complications 2,500 iu SC within 2 hr pre-op & thereafter each morning until patient is mobilised (generally 5-7 days or longer). General surgery associated with additional risk factors & orthopedic surgery Pre-op start: 5,000 iu SC the evening pre-op & 5,000 iu SC the following evenings until patient is mobilised. Alternatively, 2,500 iu SC within 2 hr pre-op & 2,500 iu SC 8-12 hr later, but no sooner than 4 hr after the end of surgery. 5,000 iu SC each morning on following days. Post-op start: 2500 iu SC 4-8 hr post-op, but no sooner than 4 hr after the end of surgery. 5,000 iu SC each morning on following days. Generally for 5-7 days or longer. Prophylaxis to patients with substantially increased risk of venous thromboembolism & that are temporarily immobilized due to acute illness such as cardiac/respiratory insufficiency, severe infections 5000 iu SC once daily for 12-14 days or longer in patients with restricted mobility. Treatment of acute deep venous thrombosis & pulmonary embolism & extended thromboprophylaxis in cancer patients 200 iu/kg SC once daily for 1st 30 days of treatment. Total daily dose: 18,000 iu daily. 150 iu/kg SC once daily for months 2-6. |
| 肝功能異常         | 需 調 整 劑 量  There are no dosage adjustments provided in the manufacturer's labeling. Use with caution in patients with severe hepatic impairment; accumulation may occur with repeated dosing, increasing the risk for bleeding.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 腎功能異常         | 需 調 整 劑 量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 懷孕用藥危分級     | 可能安全                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 哺乳期用藥建議     | Compatible 哺乳時可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 注射劑給藥建議途徑 | IV, SC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 輸注點滴液         | 【D5W】 可選 仿單建議  【N/S】 可選 仿單建議                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 注意事項           | 1. Dalteparin 不可經由肌肉注射給藥。 2. 以溶解血栓或手術治療不適合之急性深部靜脈血栓與肺栓塞治療，Dalteparin可採每天一次或每天兩次的方式，經由皮下注射(SC)給藥。 3. 預防血液透析(hemodialysis)與血液滲析(hemofiltration)期間的凝血，經由靜脈注射(IV)投與dalteparin。 4. 本注射液可與裝於玻璃或塑膠容器中的生理食鹽水溶液(0.9% NaCl)或等張葡萄糖溶液(5%)混合。Fragmin與其他藥物的相容性至今尚未進行研究，因此不可與其他藥物混合使用。                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

